The treatment of AIDS-related cytomegalovirus disease with ganciclovir and foscarnet association. Three case reports

Recenti Progressi in Medicina

Volumn 87, Issue 11, 1996, Pages 545-548

  Manfredi, Roberto ^a   Mastroianni, Antonio ^a   Coronado, Olga V ^a   Chiodo, Francesco ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

cytomegalovirus; ganciclovir foscarnet combined treatment; HIV AIDS

Indexed keywords

FOSCARNET; GANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; RETINITIS;

EID: 0030469154     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Drew WL. Cytomegalovirus infection in patients with AIDS. Clin Infect Dis 1992; 14: 608-15.
2. Katlama C. Cytomegalovirus infection in acquired immunodeficiency syndrome. J Med Virol 1993; Suppl. 1: 128-33.
3. Smith MA, Brennessel DJ. Cytomegalovirus. Infect Dis Clin North Am 1994; 8: 427-38.
4. Jacobson MA. Current management of cytomegalovirus disease in patients with AIDS. AIDS Res Hum Retroviruses 1994; 10: 917-23.
5. Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med 1992; 326: 213-20.
6. Polis MA, De Smet MD, Baird BF et al. Increased survival of a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis, who received sodium phosphonoformate (Foscarnet). Am J Med 1993; 94: 175-80.
7. Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. Foscarnet-ganciclovir cytomegalovirus retinitis trial. Visual outcomes. Ophthalmology 1994; 101: 1250-61.
8. Blanshard C, Benhamou Y, Dohin E, Lernerstedt JO, Gazzard BG, Katlama C. Treatment of AIDS-associated gastrointestinal cytomegalovirus infection with foscarnet and ganciclovir: a randomized comparison. J Infect Dis 1995; 172: 622-8.
9. Kuppermann BD, Flores Aguilar M, Quiceno JI, Rickman LS, Freeman WR. Combination of ganciclovir and foscarnet in the treatment of clinically resistant cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Arch Ophthalmol 1993; 111: 1359-66.
10. Dieterich DT, Poles MA, Dicker H et al. Foscarnet treatment of cytomegalovirus gastrointestinal infection in acquired immunodeficiency syndrome patients who have failed ganciclovir induction. Am J Gastroenterol 1993; 88: 542-8.
11. Weinberg DV, Murphy R, Naughton K. Combined daily therapy with intravenous ganciclovir and foscarnet for patients with recurrent cytomegalovirus retinitis. Am J Ophthalmol 1994; 117: 776-820.
12. Flores Aguilar M, Kuppermann BD, Quiceno JI et al. Combination of ganciclovir and foscarnet in the treatment of clinically resistant cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Ophthalmology 1993; 100: 1022-31.
13. Jacobson MA, Wulfsohn M, Feinberg JE et al. Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG Protocol 093). AIDS 1994; 8: 451-9.
14. Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Arch Intern Med 1995; 115: 65-74.
15. Peters M, Timm U, Schürmann D, Pohle HD, Ruf B. Combined and alternating ganciclovir and foscarnet in acute and maintenance therapy of human immunodeficiency virus-related cytomegalovirus encephalitis refractory to ganciclovir alone. A case report and review of the literature. Klin Wochenschr 1992; 70: 456-8.
16. Peters M, Schürmann D, Bergmann P et al. Safety of alternating ganciclovir and foscarnet maintenance therapy in human immunodeficiency virus (HIV)-related cytomegalovirus infections. An open-labeled pilot study. Scand J Infect Dis 1994; 26: 49-54.
17. Drew WI, Miner RC, Busch DF et al. Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. J Infect Dis 1991; 163: 716-9.
18. Dunn JP, MacCumber MW, Forman MS, Charache P, Apuzzo L, Jabs DA. Viral sensitivity testing in patients with cytomegalovirus retinitis clinically resistant to foscarnet or ganciclovir. Am J Ophthalmol 1995; 119: 587-96.
19. Leport C, Puget S, Pepin JM et al. Cytomegalovirus resistant to foscarnet: clinico-virologic correlation in a patient with human immunodeficiency virus. J Infect Dis 1993; 168: 1329-30.
20. Knox K, Drobiski WR, Carrigan DR. Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient. Lancet 1991; 337: 1292-3.
21. Nelson MR, Barter G, Hawkins D, Gazzard BG. Simultaneous treatment of cytomegalovirus retinitis with ganciclovir and foscarnet. Lancet 1991; 338: 250.
22. Coker RJ, Tomlinson D, Horner P, Migdal C, Harris JRW. Treatment of cytomegalovirus retinitis with ganciclovir and foscarnet. Lancet 1991; 338: 574-5.
23. Butler KM, De Smet M, Husson RN et al. Treatment of aggressive cytomegalovirus retinitis with ganciclovir in combination with foscarnet in a child infected with human immunodeficiency virus. J Pediatr 1992; 120: 483-6.
24. Enting R, De Gans J, Reisa P, Jansen C, Portegies P. Ganciclovir/foscarnet for cytomegalovirus meningoen-cephalitis in AIDS. Lancet 1992; 340: 559-60.
25. Dieterich DT, Poles MA, Lew EA et al. Concurrent use of ganciclovir and foscarnet to treat Cytomegalovirus infection in AIDS patients. J Infect Dis 1993; 167: 1184-8.
26. Salzberger B, Stoehr A, Heise W et al. Foscarnet and ganciclovir combination therapy for CMV disease in HIV-infected patient. Infection 1994; 22: 197-200.
27. Karmochkine M, Molina JM, Scieux C et al. Combined therapy with ganciclovir and foscarnet for cytomegalovirus polyradiculomyelitis in patients with AIDS. Am J Med 1994; 97: 196-7.
28. Decker CF, Tarver JH, Murray DF, Martin GJ. Prolonged concurrent use of ganciclovir and foscarnet in the treatment of polyradiculopathy due to cytomegalovirus in a patient with AIDS. Clin Infect Dis 1994; 19: 548-9.
29. Freitas VR, Fraser Smith EB, Matthews TR. Increased efficacy of ganciclovir in combination with foscarnet against cytomegalovirus and herpes simplex virus type 2 in vitro and in vivo. Antivir Res 1989; 12: 205-12.
30. Manischewitz JF, Quinnan GV, Lane HC, Wittek AE. Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro. Antimicrob Agents Chemother 1990; 34: 373-5.
31. Mazzulli T, Rubin RH, Ferraro MJ et al. Cytomegalovirus antigenemia: clinical correlations in transplant recipients and in persons with AIDS. J Clin Microbiol 1993; 31: 2824-7.